Reply  by Gottlieb, Ilan et al.
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August 10, 2010:611–5ero CCS occurred in 61%, predicting both normal nuclear and
xcellent short-term outcome, reiterating high sensitivity of CAC
esting for events and obstruction.
CAC with an effective radiation dose that approximates mam-
ography remains an effective filter for low-to-moderate pre-test
robability symptomatic patients (2). The literature, with 1,000
AC publications, is clear and, with 1 exception, consistent. CAC
esting should remain a mainstay in both diagnosis and prognosis
f the cardiac patient.
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eply
e thank the authors for their letters and for the interest in our
tudy and their thoughtful remarks. We would like to add some
omments.
As Drs. Correia and Blaha noted, the predictive values found in
ur paper (1) have slightly different meanings than commonly
tilized in other trials (2). This is so because we chose to take a
ifferent perspective. Our aim was to determine if a calcium score
CS) of 0 (positive scan for us) could predict the absence of
bstructive coronary artery disease (CAD), whereas the other trials
hey refer to examined the question of whether the presence of
alcium increases the likelihood of chest pain being related to
ignificant stenosis (2). We thank both for the opportunity to
urther clarify this issue.
Using our approach of calling a zero CS a positive scan, the
ositive predictive value refers to the ability of zero calcium to rule
ut obstructive CAD. This is in fact the same message of a
egative predictive value using the “conventional” approach. This
redictive value was low in our study: 68%. Accordingly, the
ensitivity of zero calcium to detect the absence of disease (i.e., to
ule out obstructive CAD) was also low at 45%. As Dr. Blaha toints out, when our results are interpreted from this perspective,
hey are clearly consistent with previously published studies (1,2).
We feel that our approach more accurately tests the utility of the
S when applied for this specific purpose, i.e., to rule out
bstructive disease in symptomatic patients with suspected CAD
o allow for discharge from the emergency department or to direct
utpatient investigation to other causes of chest pain.
We agree with Drs. McEvoy, Timmis, and Blaha that high-
uality research has been performed in determining the epidemi-
logic value of coronary calcium as a marker of atherosclerosis-
elated adverse events in asymptomatic individuals, and we thank
hem for stressing once again that our study did not investigate this
atient population. Our study documents the limitations of coro-
ary calcification in symptomatic individuals suspected of having
bstructive CAD. In fact, it quantifies something that experienced
linical cardiologists already know and have incorporated in their
linical practice (i.e., noncalcified plaque can rupture and cause a
yocardial infarction) and this phenomenon is not that uncom-
on, particularly among patients usually considered to be at low
isk for coronary disease (e.g., women and younger individuals) (3).
his was again confirmed in vivo in our study in which 20% of the
otally occluded vessels were free from calcification (1).
Referring to the ACCURACY (Assessment by Coronary Com-
uted Tomographic Angiography of Individuals Undergoing In-
asive Coronary Angiography) trial (4), Dr. Budoff states that it
demonstrated CAC sensitivity of 94% and specificity 42% for
50% stenosis by quantitative coronary angiography” and contin-
es by stating that “Gottlieb et al. present the opposite results
sensitivity 45% and specificity 91%), calling into question study
esign, equipment, or CAC methodology, not validity of CAC
esting.” In fact, their results are very similar to ours, just expressed
ifferently. As noted above, the ACCURACY CS sensitivity of
4% for the presence of stenosis matches our (CORE64 [Coronary
valuation Using Multi-Detector Spiral Computed Tomography
ngiography Using 64 Detectors]) CS specificity of 91% for the
bsence of stenosis, whether their specificity of 42% for the
resence of stenosis matches our sensitivity of 45% for the absence
f stenosis.
Regarding our CS methodology, we followed standard imaging
arameters and requirements recommended by the American
ollege of Cardiology/American Heart Association guidelines (5).
lthough we recognize that multidetector computed tomography
MDCT) scanners have different performance parameters as com-
ared with electron beam computed tomography (EBCT), in
linical practice, CS is more often measured with MDCT than
BCT due to the former’s much better performance in coronary
ngiography.
One could be tempted to generalize our findings to all sub-
roups of patients, mixing symptomatic and asymptomatic patients
s being the same. This is a grave mistake. Dr. Budoff states that
ur study trumps more than a 1,000 studies and that prognosis of
ero CS has been assessed in over 100,000 patients, but he
egrettably misses the fact that the vast majority of the published
S literature refers to asymptomatic patients.
Dr. Budoff questions exclusion of patients with CS600 in our
tudy. This group would, by definition, be irrelevant to our paper,
he main point of which was to demonstrate the prevalence of
ignificant disease in symptomatic patients having no coronary
alcium.
While we take the opportunity to thank Dr. Rita Redberg forhe time and effort in appraising our work and the comments on
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August 10, 2010:611–5he strength of our study, we agree with Dr. Timmis, Blaha, and
cEvoy that the associated editorial to our paper took a broader
iew than our data warrants. We acknowledge the role CS has for
isk stratification in selected asymptomatic populations as well as in
pidemiologic studies of atherosclerotic disease.
Searching for surrogate evidence of stenosis, as is the case with
S, makes the performance of the test rely heavily on the
revalence of obstructive CAD and other biological factors in the
opulation it is being applied to, rendering CS unsuitable for
uling out obstructive CAD in symptomatic patients. In summary,
e believe our work reflects the application of what we know in
athophysiology to clinical medicine and supports the results of
revious studies indicating that symptomatic patients with sus-
ected CAD should not be discharged from the emergency
epartment based solely on the results of coronary calcium scores
ssessed by unenhanced CT.
We thank the colleagues who have expressed interest in our
aper and provide a forum for further discussion of the analytic and
tatistical methods used in our paper.
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eply
he 5 letters to the editor concerning the Gottlieb et al. (1) study
nd the accompanying editorial (2) all focus on what is the value ofcoronary artery calcium score (CACS) in risk prediction and the
ole of population characteristics: age, sex, and presence and type
f symptoms in determining that value.
Drs. Timmis and Correia and I all agree that the accuracy of any
iagnostic test is dependent on the population in which it is used.
Dr. McEvoy says that “the role of CS, if any,” is in “reclassifi-
ation.” I agree with him that further research is needed to
etermine if there is any value in such reclassification.
Dr. Blaha and colleagues state that the utility of CACS is “to
uide selection of appropriate pharmacotherapy.” They cite no
eferences for this speculative statement. While this is a
otential use for CACS, there are no data to suggest that
ACS has any benefit in deciding who should receive medica-
ions for hypertension or hypercholesterolemia.
However, none of the letters address the key clinical point of
hether an imaging test such as coronary artery calcium will give
s new information that leads to better patient care and improved
utcomes. Despite the use of CACS for the last 20 years, there are
till no data for either the asymptomatic or symptomatic group to
how that this information benefits our patients. That is why
he most recent U.S. Preventive Services Task Force (USPSTF)
ecommendation statement on congestive heart disease (CHD)
isk assessment concluded that “the current evidence is insufficient
o assess the balance of benefits and harms of using the nontra-
itional risk factors studied to screen asymptomatic men and
omen with no history of CHD to prevent CHD events” (3).
he USPSTF cochairs state that the critical gap in the evidence
or screening with CACS is the lack of information on
ubsequent reductions in risk for CHD events in persons
dentified by CACS (4). Before subjecting healthy men and
omen to a test with significant radiation—2 to 7 mSv (5) or
00 chest roentgenograms—one must be able to tell patients
hat there is a benefit from having this test. With no known
enefit, CACS fails this essential criteria, and the harm,
ncluding cancer risk from radiation, and incidental findings
revail.
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